Key result
Pharmacological rate control has been shown to be non-inferior to rhythm control for clinical outcomes including mortality and cardiovascular events in patients with atrial fibrillation.
Why the study?
Does rhythm control improve mortality and cardiovascular events compared to rate control in patients with atrial fibrillation?
Does rhythm control improve mortality and cardiovascular events compared to rate control in patients with atrial fibrillation?
This review highlights that pharmacological rate control is non-inferior to rhythm control for mortality and cardiovascular events in atrial fibrillation, while noting the promising role of catheter ablation for paroxysmal atrial fibrillation.
Rate control remains appropriate for AF; leaves open whether ablation improves outcomes in selected patients.
Atrial fibrillation (AF) is an increasing global issue leading to increased hospitalizations, adverse health related events and mortality. This review focuses on the management of atrial fibrillation, in particular in the past decade, comparing two major strategies, rate or rhythm control. We evaluate the evidence for each strategy, pharmacological options and the increasing utilization of invasive techniques, in particular catheter ablation and use of implantable cardiac pacing devices. Pharmacological comparative trials evaluating both strategies have shown rate control being non-inferior to rhythm control for clinical outcomes of mortality and other cardiovascular events (including stroke). Catheter ablation techniques, involving radiofrequency ablation and recently cryoablation, have shown promising results in particular with paroxysmal AF. However, persistent AF provides ongoing challenges and will be a particular focus of continued research.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2016) conducted a review in Atrial fibrillation. Rate control vs. Rhythm control was evaluated on Mortality and other cardiovascular events (including stroke). Pharmacological rate control has been shown to be non-inferior to rhythm control for clinical outcomes including mortality and cardiovascular events in patients with atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: